M
Mark Pimentel
Researcher at Cedars-Sinai Medical Center
Publications - 366
Citations - 12985
Mark Pimentel is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Irritable bowel syndrome & Small intestinal bacterial overgrowth. The author has an hindex of 55, co-authored 327 publications receiving 10861 citations. Previous affiliations of Mark Pimentel include University of Calgary & University of California, Los Angeles.
Papers
More filters
Journal Article
Evidence-based management of irritable bowel syndrome with diarrhea.
TL;DR: The negative impact of IBS-D symptoms on QOL reported by patients indicate there is an unmet need for therapies that effectively treat and manage the symptoms of this condition, and addressing gaps in treatment is an important priority.
Journal ArticleDOI
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Brooks D. Cash,Mark Pimentel,Satish S.C. Rao,Leonard B. Weinstock,Lin Chang,Zeev Heimanson,Anthony Lembo +6 more
TL;DR: Open-label and blinded retreatment with a short course (2 weeks) of rifaximin improved IBS-QOL in patients with IBS, and the MCID in the overall IBS/QOL score was achieved by a significantly greater percentage of patients receiving double-blind rifaxin versus placebo.
Patent
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
TL;DR: The methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders were described in this article.
Journal Article
Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease.
Benjamin Basseri,Eric A. Vasiliauskas,Owen Chan,Hanlin L. Wang,Robert J. Basseri,Mark Pimentel,Edy E. Soffer,Jeffrey L. Conklin +7 more
TL;DR: The hypothesis that LE is associated with adult inflammatory bowel disease (IBD) and the disease variables that link LE and IBD were tested and a less frequent association between IBD and LE was found than was previously reported.
Journal ArticleDOI
Methane-producing human subjects have higher serum glucose levels during oral glucose challenge than non-methane producers: a pilot study of the effects of enteric methanogens on glycemic regulation
TL;DR: This study tested enteric methanogens for inflammation, which has been specifically linked to altered gut metabolism and weight gain in mice and confirmed their role in disease.